CA2262014A1 - Adipogenic differentiation of human mesenchymal stem cells - Google Patents
Adipogenic differentiation of human mesenchymal stem cellsInfo
- Publication number
- CA2262014A1 CA2262014A1 CA002262014A CA2262014A CA2262014A1 CA 2262014 A1 CA2262014 A1 CA 2262014A1 CA 002262014 A CA002262014 A CA 002262014A CA 2262014 A CA2262014 A CA 2262014A CA 2262014 A1 CA2262014 A1 CA 2262014A1
- Authority
- CA
- Canada
- Prior art keywords
- camp
- mesenchymal stem
- composition
- compound
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Abstract
A composition which comprises human mesenchymal stem cells which have the potential to differentiate into cells of more than one connective tissue type and a composition which induces cells from the mesenchymal stem cell population to differentiate into the adipogenic lineage, and a process for inducing such differentiation. The composition for inducing such differentiation comprises a glucocorticoid and a compound which stimulates cAMP production or inhibits cAMP degradation (such as a phosphodiesterase inhibitor). The process can further include isolating the adipocytes from remaining hMSCs.
Claims (11)
1. A composition which comprises human mesenchymal stem cells which have the potential to differentiate into cells of more than one connective tissue type and a substance which induces cells from the mesenchymal stem cell population to differentiate into the adipogenic lineage.
2. The composition of claim 1 wherein the substance which induces cells from the mesenchymal stem cell population to differentiate into the adipogenic lineage comprises a glucocorticoid and a member selected from the groups consisting of (i) a compound which elevates intracellular levels of cAMP and (ii) a compound which inhibits degradation of cAMP.
3. The composition of claim 2 wherein the glucocorticoid is selected from the group consisting of dexamethasone, hydrocortisone, and cortisone.
4. The composition of claim 2 wherein the substance which elevates intracellular cAMP include dibutyryl-cAMP, 8-CPT-cAMP (8-(4)-chlorophenylthio)-adenosine 3', 5' cyclic monophosphate; 8-bromo-cAMP; dioctanoyl-cAMP and Forskolin.
5. The composition of claim 2 wherein the substance which inhibits degradation of cAMP is a phosphodiesterase inhibitor selected from the group consisting of methyl isobutylxanthine, theophylline, caffeine, and indomethacin.
6. The composition of claim 2 wherein the substance which induces cells from the mesenchymal stem cell population to differential into the adipogenic lineage further comprises insulin.
7. A process for inducing a human mesenchymal stem cells to differential into adipocytes, comprising:
contacting human mesenchymal stem cells with (i) a glucocorticoid and (ii) a compound which elevates intracellular levels of cAMP, said glucocorticoid and compound being employed in an amount sufficient to induce human mesenchymal stemcells to differentiate into adipocytes.
contacting human mesenchymal stem cells with (i) a glucocorticoid and (ii) a compound which elevates intracellular levels of cAMP, said glucocorticoid and compound being employed in an amount sufficient to induce human mesenchymal stemcells to differentiate into adipocytes.
8. The process of claim 7 wherein (ii) is a compound which inhibits a compound which degrades cAMP.
9. The process of Claim 8 wherein (ii) is a phosphodiesterase inhibitor.
10. The process of Claim 9 wherein (i) and (ii) are in admixture with each other.
11. The process of Claim 7 which further comprises isolating the adipocytes from remaining hMSCs.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/700,753 US5827740A (en) | 1996-07-30 | 1996-07-30 | Adipogenic differentiation of human mesenchymal stem cells |
US08/700,753 | 1996-07-30 | ||
PCT/US1997/012356 WO1998004682A1 (en) | 1996-07-30 | 1997-07-21 | Adipogenic differentiation of human mesenchymal stem cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2262014A1 true CA2262014A1 (en) | 1998-02-05 |
CA2262014C CA2262014C (en) | 2010-09-14 |
Family
ID=24814738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2262014A Expired - Fee Related CA2262014C (en) | 1996-07-30 | 1997-07-21 | Adipogenic differentiation of human mesenchymal stem cells |
Country Status (11)
Country | Link |
---|---|
US (3) | US5827740A (en) |
EP (2) | EP1659172A1 (en) |
JP (1) | JP2001523084A (en) |
AT (1) | ATE342349T1 (en) |
AU (1) | AU3729097A (en) |
CA (1) | CA2262014C (en) |
DE (1) | DE69736814T2 (en) |
DK (1) | DK0954565T3 (en) |
ES (1) | ES2274547T3 (en) |
PT (1) | PT954565E (en) |
WO (1) | WO1998004682A1 (en) |
Families Citing this family (184)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
EP0974648A4 (en) * | 1997-03-07 | 2002-11-20 | Chugai Pharmaceutical Co Ltd | Novel cell line and screening method with the use of the same |
US6153432A (en) * | 1999-01-29 | 2000-11-28 | Zen-Bio, Inc | Methods for the differentiation of human preadipocytes into adipocytes |
US20050076396A1 (en) * | 1999-03-10 | 2005-04-07 | Katz Adam J. | Adipose-derived stem cells and lattices |
KR100968165B1 (en) | 1999-03-10 | 2010-07-06 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | Adipose-derived stem cells and lattices |
US6777231B1 (en) * | 1999-03-10 | 2004-08-17 | The Regents Of The University Of California | Adipose-derived stem cells and lattices |
US20030082152A1 (en) * | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
AU2003901668A0 (en) * | 2003-03-28 | 2003-05-01 | Medvet Science Pty. Ltd. | Non-haemopoietic precursor cells |
AUPQ147799A0 (en) * | 1999-07-07 | 1999-07-29 | Medvet Science Pty. Ltd. | Mesenchymal precursor cell |
US7670628B2 (en) * | 1999-07-07 | 2010-03-02 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
US8062675B2 (en) | 1999-07-07 | 2011-11-22 | Angioblast Systems, Inc. | Mesenchymal precursor cell |
US20050158289A1 (en) * | 1999-07-07 | 2005-07-21 | Simmons Paul J. | Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals |
EP2348104A1 (en) | 1999-08-05 | 2011-07-27 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
JP2003517858A (en) * | 1999-11-05 | 2003-06-03 | ジェリジーン メディカル コーポレーション | Augmentation and repair of age-related soft tissue defects |
AU3081801A (en) | 1999-11-15 | 2001-05-30 | Chemclean Corporation | Bio-burden visualization system |
ATE445158T1 (en) * | 2000-06-14 | 2009-10-15 | Vistagen Inc | TOXICITY TYPING USING LIVER STEM CELLS |
DE60130464T2 (en) * | 2000-07-18 | 2008-06-12 | Société des Produits Nestlé S.A. | PRE-ADIPOSE CELL LINES |
IL156303A0 (en) | 2000-12-06 | 2004-01-04 | Robert J Hariri | Method of collecting placental stem cells |
US7311905B2 (en) | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
US6869766B2 (en) * | 2000-12-22 | 2005-03-22 | The Regents Of The University Of California | Gene associated with regulation of adiposity and insulin response |
EP2316463B1 (en) | 2001-02-14 | 2017-04-12 | Anthrogenesis Corporation | Tissue matrices comprising placental stem cells, and methods of making them |
EP2314673B1 (en) | 2001-02-14 | 2013-07-24 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US7651684B2 (en) * | 2001-12-07 | 2010-01-26 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
US7585670B2 (en) | 2001-12-07 | 2009-09-08 | Cytori Therapeutics, Inc. | Automated methods for isolating and using clinically safe adipose derived regenerative cells |
US7595043B2 (en) | 2001-12-07 | 2009-09-29 | Cytori Therapeutics, Inc. | Method for processing and using adipose-derived stem cells |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
EP2305276A3 (en) | 2001-12-07 | 2011-09-21 | Cytori Therapeutics, Inc. | Processed lipoaspirate cells for use in therapy |
US20060204556A1 (en) * | 2001-12-07 | 2006-09-14 | Cytori Therapeutics, Inc. | Cell-loaded prostheses for regenerative intraluminal applications |
US7514075B2 (en) * | 2001-12-07 | 2009-04-07 | Cytori Therapeutics, Inc. | Systems and methods for separating and concentrating adipose derived stem cells from tissue |
US8404229B2 (en) | 2001-12-07 | 2013-03-26 | Cytori Therapeutics, Inc. | Methods of using adipose derived stem cells to treat acute tubular necrosis |
US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
WO2006075986A1 (en) * | 2005-01-10 | 2006-07-20 | Macropore Biosurgery, Inc. | Devices and methods for monitoring, managing, and servicing medical devices |
US20050048036A1 (en) * | 2001-12-07 | 2005-03-03 | Hedrick Marc H. | Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
US20050048035A1 (en) * | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
AU2002366802A1 (en) * | 2001-12-20 | 2003-07-09 | Macropore, Inc. | Systems and methods for treating patients with collagen-rich material extracted from adipose tissue |
JP4545440B2 (en) * | 2002-01-04 | 2010-09-15 | ヘンリー フォード ヘルス システム | Nitric oxide donors for treatment of disease and injury |
CA2476275A1 (en) * | 2002-02-07 | 2003-08-14 | University Of Miami | Schwann cell bridge implants and phosphodiesterase inhibitors to stimulate cns nerve regeneration |
US7700090B2 (en) | 2002-02-13 | 2010-04-20 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
AU2003213666A1 (en) * | 2002-03-02 | 2003-09-16 | Board Of Regents, The University Of Texas System | Local production and/or delivery of anti-cancer agents by stromal cell precursors |
AU2003220424A1 (en) * | 2002-03-19 | 2003-10-08 | Advanced Research And Technology Transfer | Adipose stromal stem cells for tissue and vascular modification |
TWI288779B (en) * | 2002-03-28 | 2007-10-21 | Blasticon Biotech Forschung | Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
WO2003084468A2 (en) * | 2002-04-03 | 2003-10-16 | Artecel Sciences, Inc. | Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
US7060494B2 (en) * | 2002-04-09 | 2006-06-13 | Reliance Life Sciences Pvt. Ltd. | Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof |
US20050118715A1 (en) * | 2002-04-12 | 2005-06-02 | Hariri Robert J. | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
KR20050008757A (en) * | 2002-05-30 | 2005-01-21 | 셀진 코포레이션 | Methods of using jnk or mkk inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
KR20100125479A (en) * | 2002-11-26 | 2010-11-30 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
US20040219136A1 (en) * | 2003-02-13 | 2004-11-04 | Hariri Robert J | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
KR100865884B1 (en) | 2003-03-18 | 2008-10-31 | (주)안트로젠 | Differentiated adipocyte for allogenic transplantation |
AU2004227342B2 (en) * | 2003-04-01 | 2011-01-20 | United States Of America Department Of Veteran's Affairs | Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
EP1702062A2 (en) * | 2003-06-11 | 2006-09-20 | Jan Remmereit | Differentiation of stem cells for therapeutic use |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
US7012273B2 (en) * | 2003-08-14 | 2006-03-14 | Silicon Storage Technology, Inc. | Phase change memory device employing thermal-electrical contacts with narrowing electrical current paths |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
WO2005033297A1 (en) * | 2003-09-19 | 2005-04-14 | The Rockefeller University | Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
EP2450433A3 (en) * | 2003-10-08 | 2012-08-08 | Vet-Stem Inc | Methods of preparing and using stem cell compositions and kits comprising the same |
WO2005079250A2 (en) * | 2004-02-13 | 2005-09-01 | Cornell Research Foundation, Inc. | Purines are self-renewal signals for neural stem cells, and purine receptor antagonists promote neuronal and glial differentiation therefrom |
US7622108B2 (en) | 2004-04-23 | 2009-11-24 | Bioe, Inc. | Multi-lineage progenitor cells |
CN101080486B (en) | 2004-04-23 | 2012-05-16 | 佰欧益股份有限公司 | Multi-lineage progenitor cells |
CN101103101B (en) | 2004-09-24 | 2012-10-10 | 成血管细胞系统公司 | Method of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) |
WO2006052991A2 (en) | 2004-11-11 | 2006-05-18 | The General Hosptial Corporation | Parathyroid hormone receptor activation and stem and progenitor cell expansion |
WO2006062989A1 (en) * | 2004-12-07 | 2006-06-15 | Bacterin International, Inc. | Three-dimensional cell culsture system |
CA2512667A1 (en) * | 2005-01-07 | 2006-07-07 | Takahiro Ochiya | Human hepatocyte-like cells and uses thereof |
WO2006121445A2 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
US8613906B2 (en) | 2005-05-27 | 2013-12-24 | Viacord, Llc | Treatment of ischemia using stem cells |
US8568761B2 (en) * | 2005-07-15 | 2013-10-29 | Cormatrix Cardiovascular, Inc. | Compositions for regenerating defective or absent myocardium |
US7531355B2 (en) | 2005-07-29 | 2009-05-12 | The Regents Of The University Of California | Methods and compositions for smooth muscle reconstruction |
MX2008001709A (en) * | 2005-08-01 | 2008-11-26 | Nupotential Inc | Production of reprogrammed cells with restored potential. |
CA2629405C (en) | 2005-09-09 | 2016-06-21 | Duke University | Tissue engineering methods and compositions |
MX343814B (en) | 2005-10-13 | 2016-11-24 | Anthrogenesis Corp | Immunomodulation using placental stem cells. |
US20080070303A1 (en) * | 2005-11-21 | 2008-03-20 | West Michael D | Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby |
PT2471905T (en) | 2005-12-29 | 2019-01-11 | Celularity Inc | Placental stem cell populations |
AU2007209870A1 (en) * | 2006-01-30 | 2007-08-09 | University Of Virginia Patent Foundation | Methods of preparing and characterizing mesenchymal stem cell aggregates and uses thereof |
EP2019858B1 (en) | 2006-04-17 | 2012-06-13 | BioE LLC | Differentiation of multi-lineage progenitor cells to respiratory epithelial cells |
US20090304644A1 (en) * | 2006-05-30 | 2009-12-10 | Cytori Therapeutics, Inc. | Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue |
KR20090031895A (en) * | 2006-06-09 | 2009-03-30 | 안트로제네시스 코포레이션 | Placental niche and use thereof to culture stem cells |
WO2008013863A2 (en) * | 2006-07-26 | 2008-01-31 | Cytori Therapeutics, Inc. | Generation of adipose tissue and adipocytes |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
JP2010505849A (en) * | 2006-10-06 | 2010-02-25 | ユニバーシティ オブ バージニア パテント ファウンデーション | Methods and compositions useful for diabetic wound healing |
WO2008051568A2 (en) | 2006-10-23 | 2008-05-02 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
TW200822930A (en) * | 2006-11-22 | 2008-06-01 | Chao-Song Hsue | Composition for reducing weight and curing hypertriglyceridemia, the effective ingredients thereof containing cyclic AMP, nicotinic acid, prostaglandin, gamma linolenic acid, and xanthine derivates |
CN103356711A (en) | 2007-02-12 | 2013-10-23 | 人类起源公司 | Immunomodulation using placental stem cells |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
US7632340B2 (en) * | 2007-03-07 | 2009-12-15 | Hamilton Beach Brands, Inc. | Air purifier for removing particles or contaminants from air |
EP2607477B1 (en) | 2007-05-03 | 2020-09-23 | The Brigham and Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
US8574567B2 (en) * | 2007-05-03 | 2013-11-05 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
TWM322542U (en) * | 2007-05-23 | 2007-11-21 | Universal Scient Ind Co Ltd | Testing machine |
WO2009015343A2 (en) * | 2007-07-25 | 2009-01-29 | Bioe, Inc. | Differentiation of multi-lineage progenitor cells to chondrocytes |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
CN101978045A (en) * | 2007-09-26 | 2011-02-16 | 细胞基因细胞疗法公司 | Angiogenic cells from human placental perfusate |
ES2719931T3 (en) | 2007-09-28 | 2019-07-16 | Celularity Inc | Tumor suppression using human placental perfusate and intermediate natural killer cells that come from human placenta |
KR20170116221A (en) * | 2007-11-07 | 2017-10-18 | 안트로제네시스 코포레이션 | Use of umbilical cord blood in the treatment of premature birth complications |
US20100278788A1 (en) * | 2008-01-11 | 2010-11-04 | Bone Therapeutics, S.A. | Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors |
US20100189338A1 (en) * | 2008-04-09 | 2010-07-29 | Nexcelom Bioscience | Systems and methods for counting cells and biomolecules |
CN102083969A (en) * | 2008-05-06 | 2011-06-01 | 乔斯林糖尿病中心股份有限公司 | Methods and compositions for inducing brown adipogenesis |
BE1018748A3 (en) | 2008-05-07 | 2011-08-02 | Bone Therapeutics Sa | NOVEL MESENCHYMAL STEM CELLS AND OSTEOGENIC CELLS. |
CA2724839A1 (en) * | 2008-05-21 | 2009-11-26 | Bioe Llc | Differentiation of multi-lineage progenitor cells to pancreatic cells |
ES2608974T3 (en) * | 2008-08-14 | 2017-04-17 | Mesoblast International Sàrl | Compositions of purified mesenchymal stem cells |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
CA2734237C (en) | 2008-08-20 | 2019-07-02 | Anthrogenesis Corporation | Treatment of stroke using isolated placental cells |
WO2010021714A2 (en) | 2008-08-20 | 2010-02-25 | Anthrogenesis Corporation | Improved cell composition and methods of making the same |
MX2011001992A (en) | 2008-08-22 | 2011-03-29 | Anthrogenesis Corp | Methods and compositions for treatment of bone defects with placental cell populations. |
EP2182055A1 (en) | 2008-10-14 | 2010-05-05 | Heinrich-Heine-Universität Düsseldorf | Human cord blood derived unrestricted somatic stem cells (USSC) |
US20100098739A1 (en) * | 2008-10-20 | 2010-04-22 | University Of Virginia Patent Foundation | Compositions and methods for modular soft tissue repair |
RU2015130665A (en) | 2008-11-19 | 2018-12-24 | Антродженезис Корпорейшн | AMNIOTIC ADHESIVE CELLS |
US9192695B2 (en) | 2008-11-20 | 2015-11-24 | Allosource | Allografts combined with tissue derived stem cells for bone healing |
NZ592839A (en) * | 2008-11-21 | 2012-10-26 | Anthrogenesis Corp | Treatment of diseases, disorders or conditions of the lung using placental cells |
EP2424463B1 (en) | 2009-05-01 | 2016-12-28 | Bimini Technologies LLC | Systems, methods and compositions for optimizing tissue and cell enriched grafts |
US9301975B2 (en) | 2009-05-01 | 2016-04-05 | Biocardia, Inc. | Method of preparing autologous cells and method of use for therapy |
MX2012000110A (en) | 2009-07-02 | 2012-04-02 | Anthrogenesis Corp | Method of producing erythrocytes without feeder cells. |
SG10201404281YA (en) | 2009-07-21 | 2014-09-26 | Abt Holding Co | Use of stem cells to reduce leukocyte extravasation |
US20110020293A1 (en) | 2009-07-21 | 2011-01-27 | Abt Holding Company | Use of Stem Cells to Reduce Leukocyte Extravasation |
US20120263685A1 (en) * | 2009-10-08 | 2012-10-18 | Rnl Bio Co., Ltd | Anti-tumor composition comprising human-derived adult stem cells |
EP2489727A4 (en) * | 2009-10-08 | 2013-05-08 | Seoul Nat Univ Hospital | Method of inducing high activity of human adipose stem cell and medium therefor |
US8476227B2 (en) | 2010-01-22 | 2013-07-02 | Ethicon Endo-Surgery, Inc. | Methods of activating a melanocortin-4 receptor pathway in obese subjects |
US9044606B2 (en) | 2010-01-22 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue using electrical energy |
KR20120115602A (en) | 2010-01-26 | 2012-10-18 | 안트로제네시스 코포레이션 | Treatment of bone-related cancers using placental stem cells |
SG10201914001QA (en) | 2010-02-25 | 2020-03-30 | Abt Holding Co | Modulation of macrophage activation |
TWI756797B (en) | 2010-04-07 | 2022-03-01 | 美商瑟魯勒瑞堤股份有限公司 | Angiogenesis using placental stem cells |
CN102933221A (en) | 2010-04-08 | 2013-02-13 | 人类起源公司 | Treatment of sarcoidosis using placental stem cells |
JP5968871B2 (en) | 2010-04-13 | 2016-08-10 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | Production of hepatocytes by forward programming |
JP2013530699A (en) | 2010-06-15 | 2013-08-01 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | Overview of ready-made stem cell models for investigating biological responses |
JP5897002B2 (en) | 2010-07-07 | 2016-04-13 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | Endothelial cell production by programming |
EP3366327B1 (en) | 2010-07-09 | 2022-09-21 | GID BIO, Inc. | Apparatus and methods relating to collecting and processing human biological material containing adipose |
US9206387B2 (en) | 2010-07-09 | 2015-12-08 | The Gid Group, Inc. | Method and apparatus for processing adipose tissue |
WO2013106655A1 (en) | 2012-01-11 | 2013-07-18 | The Gid Group, Inc. | Method for processing adipose tissue and processing apparatus |
WO2014039697A1 (en) | 2012-09-06 | 2014-03-13 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US9296984B2 (en) | 2010-07-09 | 2016-03-29 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
CN103097520B (en) | 2010-07-13 | 2017-12-05 | 人类起源公司 | The method for producing NK |
US20130259807A1 (en) * | 2010-09-01 | 2013-10-03 | The Regents Of The University Of California | Cell culture screen for agents that control adipogenesis and myofibroblast differentiation |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
US9381219B2 (en) | 2010-12-29 | 2016-07-05 | Ethicon Endo-Surgery, Inc. | Brown adipocyte modification |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
PT2667878E (en) | 2011-01-25 | 2016-06-03 | Univ Catholique Louvain | Compositions and methods for cell transplantation |
JP6005666B2 (en) | 2011-02-08 | 2016-10-12 | セルラー ダイナミクス インターナショナル, インコーポレイテッド | Production of hematopoietic progenitor cells by programming |
MX357749B (en) | 2011-06-01 | 2018-07-23 | Anthrogenesis Corp | Treatment of pain using placental stem cells. |
DK2718416T3 (en) | 2011-06-06 | 2020-02-24 | ReGenesys BVBA | Expansion of stem cells in hollow fiber bioreactors |
US10865383B2 (en) | 2011-07-12 | 2020-12-15 | Lineage Cell Therapeutics, Inc. | Methods and formulations for orthopedic cell therapy |
US9925221B2 (en) | 2011-09-09 | 2018-03-27 | Celularity, Inc. | Treatment of amyotrophic lateral sclerosis using placental stem cells |
BE1020528A3 (en) | 2011-10-11 | 2013-12-03 | Bone Therapeutics Sa | USES OF THE GROWTH AND DIFFERENTIATION FACTOR 8 (GDF 8). |
WO2013082106A1 (en) | 2011-12-02 | 2013-06-06 | The General Hospital Corporation | Differentiation into brown adipocytes |
EP2806879B1 (en) | 2012-01-25 | 2019-03-06 | Université Catholique de Louvain | Compositions and methods for cell transplantation |
US10041039B2 (en) | 2012-03-29 | 2018-08-07 | Jcr Pharmaceuticals Co., Ltd. | Method for producing pluripotent stem cells derived from dental pulp |
DK2900247T3 (en) | 2012-09-26 | 2018-03-05 | Bone Therapeutics Sa | COMPOSITIONS OF SOLVENT / DETERGENT-TREATED PLASMA AND HYALURONIC ACID FOR USE IN TREATMENT OF MUSCULOSKELETAL DISORDERS |
CN105008396A (en) | 2012-11-25 | 2015-10-28 | 加利福尼亚大学董事会 | Peptides that stimulate subcutaneous adipogenesis |
AU2014215458A1 (en) | 2013-02-05 | 2015-08-13 | Anthrogenesis Corporation | Natural killer cells from placenta |
WO2014130770A1 (en) | 2013-02-22 | 2014-08-28 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
WO2014150784A1 (en) | 2013-03-15 | 2014-09-25 | Allosource | Cell repopulated collagen matrix for soft tissue repair and regeneration |
EP2981605B1 (en) | 2013-04-03 | 2019-06-19 | FUJIFILM Cellular Dynamics, Inc. | Methods and compositions for culturing endoderm progenitor cells in suspension |
CN115177637A (en) | 2013-04-12 | 2022-10-14 | 休斯顿卫理公会医院 | Improvements in organs for transplantation |
AU2014266935B2 (en) | 2013-04-30 | 2020-06-11 | Katholieke Universiteit Leuven | Cell therapy for myelodysplastic syndromes |
EP3038629B1 (en) | 2013-09-05 | 2020-11-18 | GID BIO, Inc. | Method for processing adipose tissue |
CN105992816B (en) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | Cell amplification in bioreactor |
EP3122866B1 (en) | 2014-03-25 | 2019-11-20 | Terumo BCT, Inc. | Passive replacement of media |
WO2015164228A1 (en) | 2014-04-21 | 2015-10-29 | Cellular Dynamics International, Inc. | Hepatocyte production via forward programming by combined genetic and chemical engineering |
WO2015184125A1 (en) | 2014-05-28 | 2015-12-03 | The Regents Of The University Of California | Peptides, compositions, and methods for stimulating subcutaneous adipogenesis |
CA2961715C (en) | 2014-09-19 | 2019-04-30 | Osiris Therapeutics, Inc. | Bone repair product and methods of use thereof |
US20170296589A1 (en) | 2014-09-23 | 2017-10-19 | Case Western Reserve University | Compositions and methods for treating lung remodeling diseases |
EP3198006B1 (en) | 2014-09-26 | 2021-03-24 | Terumo BCT, Inc. | Scheduled feed |
KR101629151B1 (en) * | 2014-11-07 | 2016-06-10 | 한양대학교 에리카산학협력단 | Composition including stem cell-derived exosome for inducing adipogenic differentiation and adipose tissue regeneration |
ES2831298T3 (en) | 2014-11-07 | 2021-06-08 | Exocobio Inc | Composition that includes exosomes derived from stem cells to whiten the skin or improve wrinkles |
US10080884B2 (en) | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
BR112017022656A2 (en) | 2015-04-23 | 2018-07-17 | Bone Therapeutics Sa | in vitro conservation of therapeutic cells |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
WO2017210537A1 (en) | 2016-06-02 | 2017-12-07 | The Cleveland Clinic Foundation | Complement inhibition for improving cell viability |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
AU2017319140B2 (en) | 2016-08-30 | 2022-11-17 | Lifecell Corporation | Systems and methods for medical device control |
USD851777S1 (en) | 2017-01-30 | 2019-06-18 | Lifecell Corporation | Canister-type device for tissue processing |
US11702634B2 (en) | 2017-03-31 | 2023-07-18 | Terumo Bct, Inc. | Expanding cells in a bioreactor |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
WO2019018002A1 (en) | 2017-07-18 | 2019-01-24 | The Gid Group, Inc. | Adipose tissue digestion system and tissue processing method |
SG11202003524XA (en) | 2017-10-20 | 2020-05-28 | Bone Therapeutics Sa | Methods for differentiating mesenchymal stem cells |
EP3708654A4 (en) * | 2017-11-16 | 2020-12-23 | Nissan Chemical Corporation | Method for inducing differentiation into and producing beige and white adipocytes |
CN112469815A (en) | 2018-07-31 | 2021-03-09 | Jcr制药股份有限公司 | Method for producing dental pulp-derived cells |
JP2022501053A (en) | 2018-09-25 | 2022-01-06 | ボーン、セラピューティクス、エスアーBone Thrapeutics Sa | Methods for Differentiating Mesenchymal Stem Cells |
CN113260713A (en) | 2018-09-25 | 2021-08-13 | 骨治疗股份公司 | Method and use for determining osteogenic potential of in vitro differentiated cells |
AR118008A1 (en) | 2019-02-07 | 2021-09-08 | Vitricell Sa | COMPOSITIONS FOR CRYOPRESERVATION OF A BIOLOGICAL MATERIAL |
BE1027216B1 (en) | 2019-05-13 | 2021-06-21 | Bone Therapeutics | ENHANCED LYOPHILIZED FORMULATIONS INCLUDING HYALURONIC ACID AND PLASMATIC PROTEINS, AND THEIR USES |
US20220364059A1 (en) | 2019-07-05 | 2022-11-17 | Case Western Reserve University | Priming media and methods for stem cell culture and therapy |
TW202146033A (en) | 2020-01-30 | 2021-12-16 | 日商Jcr製藥股份有限公司 | Medicinal composition comprising dental pulp-derived cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
-
1996
- 1996-07-30 US US08/700,753 patent/US5827740A/en not_active Expired - Lifetime
-
1997
- 1997-07-21 WO PCT/US1997/012356 patent/WO1998004682A1/en active IP Right Grant
- 1997-07-21 EP EP06002113A patent/EP1659172A1/en not_active Ceased
- 1997-07-21 PT PT97934171T patent/PT954565E/en unknown
- 1997-07-21 CA CA2262014A patent/CA2262014C/en not_active Expired - Fee Related
- 1997-07-21 AT AT97934171T patent/ATE342349T1/en not_active IP Right Cessation
- 1997-07-21 JP JP50885998A patent/JP2001523084A/en active Pending
- 1997-07-21 ES ES97934171T patent/ES2274547T3/en not_active Expired - Lifetime
- 1997-07-21 DK DK97934171T patent/DK0954565T3/en active
- 1997-07-21 AU AU37290/97A patent/AU3729097A/en not_active Abandoned
- 1997-07-21 DE DE69736814T patent/DE69736814T2/en not_active Expired - Lifetime
- 1997-07-21 EP EP97934171A patent/EP0954565B1/en not_active Expired - Lifetime
-
1998
- 1998-10-26 US US09/246,003 patent/US6322784B1/en not_active Expired - Lifetime
-
2000
- 2000-03-28 US US09/537,003 patent/US6709864B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6322784B1 (en) | 2001-11-27 |
ATE342349T1 (en) | 2006-11-15 |
DE69736814D1 (en) | 2006-11-23 |
AU3729097A (en) | 1998-02-20 |
JP2001523084A (en) | 2001-11-20 |
DK0954565T3 (en) | 2007-02-05 |
PT954565E (en) | 2007-01-31 |
CA2262014C (en) | 2010-09-14 |
EP0954565A1 (en) | 1999-11-10 |
EP0954565A4 (en) | 2002-09-18 |
DE69736814T2 (en) | 2007-08-16 |
EP1659172A1 (en) | 2006-05-24 |
EP0954565B1 (en) | 2006-10-11 |
US5827740A (en) | 1998-10-27 |
WO1998004682A1 (en) | 1998-02-05 |
ES2274547T3 (en) | 2007-05-16 |
US6709864B1 (en) | 2004-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2262014A1 (en) | Adipogenic differentiation of human mesenchymal stem cells | |
Taylor et al. | Multiple new phenotypes induced in 10T12 and 3T3 cells treated with 5-azacytidine | |
Beebe et al. | Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes. | |
Waisman et al. | The modulator-dependent protein kinase. A multifunctional protein kinase activatable by the Ca2+-dependent modulator protein of the cyclic nucleotide system. | |
Habuchi et al. | Coordinate regulation of collagen and alkaline phosphatase levels in chick embryo chondrocytes. | |
Gariglio et al. | Sarkosyl activation of RNA polymerase activity in mitotic mouse cells | |
Jard et al. | A cyclic AMP-dependent protein kinase from frog bladder epithelial cells | |
Naor et al. | Induction of exocytosis in permeabilized pituitary cells by alpha-and beta-type protein kinase C. | |
Kiechle et al. | Isolation from rat adipocytes of a chemical mediator for insulin activation of pyruvate dehydrogenase | |
Brown et al. | Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. | |
Eto et al. | Enzymatic synthesis of biopterin from D-erythrodihydroneopterin triphosphate by extracts of kidneys from Syrian golden hamsters. | |
Schlondorff et al. | Cyclic nucleotide metabolism in compensatory renal hypertrophy and neonatal kidney growth. | |
Live et al. | Changes in adenylate energy charge in Ehrlich ascites tumor cells deprived of serum, glucose, or amino acids. | |
Whitfield et al. | The possible mediation by cyclic AMP of the stimulation of thymocyte proliferation by cyclic GMP | |
Bökkerink et al. | Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages | |
Thomson et al. | The metabolic stability of the nucleic acids in cultures of a pure strain of mammalian cells | |
Shoji et al. | Guanosine cyclic monophosphate-dependent protein kinase from foetal calf heart. Purification, general properties and catalytic subunit | |
Milstien et al. | Hepatic phenylalanine 4-monooxygenase is a phosphoprotein. | |
Said et al. | Intracellular regulation of intestinal folate uptake: studies with cultured IEC-6 epithelial cells | |
Estes et al. | Inhibition of lymphocyte stimulation by cyclic and non-cyclic nucleotides | |
Bisgaier et al. | Activation of sterol ester hydrolase of bovine corpus luteum by N6, O2′‐dibutyryl cyclic adenosine 3′∶ 5′‐phosphate | |
Kuo et al. | Activation and dissociation of adenosine 3′, 5′-monophosphate-dependent and guanosine 3′, 5′-monophosphate-dependent protein kinases by various cyclic nucleotide analogs | |
Lopez-s et al. | Effect of 17-ketosteroids on glucose-6-phosphate dehydrogenase activity (G6PD) and on G6PD isoenzymes | |
Cline et al. | Orthophosphate excretion as related to RNA metabolism in Tetrahymena | |
Glazer et al. | Inhibitory effects of cordycepin on cyclic nucleotide-dependent and cyclic nucleotide-independent protein kinases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |